Association of HLA genotypes, AB0 blood type and chemokine receptor 5 mutant CD195 with the clinical course of COVID-19.

MLA

Fischer, Johannes C., et al. “Association of HLA Genotypes, AB0 Blood Type and Chemokine Receptor 5 Mutant CD195 with the Clinical Course of COVID-19.” European Journal of Medical Research, vol. 26, no. 1, Sept. 2021, p. 107. EBSCOhost, https://doi.org/10.1186/s40001-021-00560-4.

APA

Fischer, J. C., Schmidt, A. G., Bölke, E., Uhrberg, M., Keitel, V., Feldt, T., Jensen, B., Häussinger, D., Adams, O., Schneider, E. M., Balz, V., Enczmann, J., Rox, J., Hermsen, D., Schulze-Bosse, K., Kindgen-Milles, D., Knoefel, W. T., van Griensven, M., Haussmann, J., … Matuschek, C. (2021). Association of HLA genotypes, AB0 blood type and chemokine receptor 5 mutant CD195 with the clinical course of COVID-19. European Journal of Medical Research, 26(1), 107. https://doi.org/10.1186/s40001-021-00560-4

Chicago

Fischer, Johannes C, Albrecht G Schmidt, Edwin Bölke, Markus Uhrberg, Verena Keitel, Torsten Feldt, Björn Jensen, et al. 2021. “Association of HLA Genotypes, AB0 Blood Type and Chemokine Receptor 5 Mutant CD195 with the Clinical Course of COVID-19.” European Journal of Medical Research 26 (1): 107. doi:10.1186/s40001-021-00560-4.